Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan

Sadayoshi Ito, Hiroaki Naritomi, Toshio Ogihara, Kazuyuki Shimada, Kazuaki Shimamoto, Heizo Tanaka, Nobuo Yoshiike

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

High serum uric acid level (SUA) and chronic kidney disease (CKD) are risk factors for cardiovascular events (CVEs). However, their interactions as cardiovascular risk factors remain unknown. This subanalysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study included 7629 patients, in whom the serum creatinine level was measured at least twice. The study examined the impact of hyperuricemia (SUA ≥7mgdl-1) on CVE according to the level of renal dysfunction and whether early changes in SUA predicted future glomerular filtration rates (GFRs). The mean follow-up period was 3.1 years. The patients were divided into three groups according to the baseline estimated GFR (eGFR): groups A, B and C with eGFR <45, 45-59 and ≥60 ml min-1 per 1.73m2, respectively. eGFR increased from 38.1 to 57.6, from 52.8 to 67.5 and from 74.7 to 80.7 ml min-1 per 1.73m2 in groups A, B and C, respectively. In non-hyperuricemic patients, the CVE rate was 10.83, 4.98 and 4.21/1000 person-years in groups A, B and C, respectively, while in hyperuricemic patients, the corresponding values were 14.18, 17.02 and 5.93. Thus, hyperuricemia increased the risk of CVE only in group B (relative risk (RR) 3.43 (95% confidence interval (CI) 1.55 to 7.60); Po0.002). The final change in the eGFR was negatively correlated with the change in SUA from baseline to year 1 (Po0.001). CVEs were more frequent in those with a decrease in eGFR. Hyperuricemia may be a major determinant of increased cardiovascular risk in CKD stage 3A, and SUA may be involved in the progression of CKD. Changes in the GFR influence the rate of CVE.

Original languageEnglish
Pages (from-to)867-873
Number of pages7
JournalHypertension Research
Volume35
Issue number8
DOIs
Publication statusPublished - 2012 Aug 1

Keywords

  • cardiovascular disease
  • chronic kidney disease
  • glomerular filtration rate
  • uric acid

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan'. Together they form a unique fingerprint.

  • Cite this

    Ito, S., Naritomi, H., Ogihara, T., Shimada, K., Shimamoto, K., Tanaka, H., & Yoshiike, N. (2012). Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertension Research, 35(8), 867-873. https://doi.org/10.1038/hr.2012.59